We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

135 hedge funds and large institutions have $1.11B invested in Immunogen Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more call options, than puts

Call options by funds: $8.63M | Put options by funds: $8.36M

8% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 50

4% less funds holding

Funds holding: 141135 (-6)

12% less capital invested

Capital invested by funds: $1.25B → $1.11B (-$148M)

29% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
135
Holders Change
-6
Holders Change %
-4.26%
% of All Funds
3.92%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.06%
New
12
Increased
46
Reduced
50
Closed
17
Calls
$8.63M
Puts
$8.36M
Net Calls
+$269K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
76
UBS AM
Illinois
$428K -$13.8K -900 -3%
Principal Financial Group
77
Principal Financial Group
Iowa
$426K -$2.4K -156 -0.5%
DADC
78
D.A. Davidson & Co
Montana
$426K +$37K +2,405 +9%
CIBC World Market
79
CIBC World Market
Ontario, Canada
$374K -$57.5K -3,744 -13%
William Blair & Company
80
William Blair & Company
Illinois
$354K -$21.7K -1,409 -6%
AQR Capital Management
81
AQR Capital Management
Connecticut
$339K
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$331K -$93.9K -6,109 -21%
SCM
83
Stonebridge Capital Management
California
$325K +$36.9K +2,400 +12%
PI
84
Placemark Investments
Illinois
$315K +$33.3K +2,164 +11%
T. Rowe Price Associates
85
T. Rowe Price Associates
Maryland
$312K
Neuberger Berman Group
86
Neuberger Berman Group
New York
$312K +$891 +58 +0.3%
Nomura Holdings
87
Nomura Holdings
Japan
$311K +$326K +21,208 New
FBA
88
Front Barnett Associates
Illinois
$304K -$23.1K -1,500 -7%
Comerica Bank
89
Comerica Bank
Texas
$302K -$631K -41,054 -67%
AT
90
Arden Trust
Delaware
$285K +$17.6K +1,145 +6%
DTL
91
Dynamic Technology Lab
Singapore
$264K +$46.3K +3,013 +20%
Creative Planning
92
Creative Planning
Kansas
$232K +$199K +12,967 +458%
Cambridge Investment Research Advisors
93
Cambridge Investment Research Advisors
Iowa
$226K +$10.8K +700 +5%
V
94
Veritable
Delaware
$202K +$17.7K +1,153 +9%
Commonwealth Equity Services
95
Commonwealth Equity Services
Massachusetts
$199K -$69.7K -4,532 -25%
PCM
96
Prelude Capital Management
New York
$193K
N
97
Nuveen
North Carolina
$192K +$7.84K +510 +4%
VKH
98
Virtu KCG Holdings
New York
$186K -$85.4K -5,560 -30%
DC
99
Deere & Company
Illinois
$177K +$185K +12,064 New
NCCM
100
Nine Chapters Capital Management
New Jersey
$176K -$148K -9,600 -44%

IMGN Hedge Fund Activity: Q4 2013 in Review

135 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2013, worth a combined $1.11B — down 12% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of IMGN and 12 opened new positions — a net loss of 5 holders — while 50 trimmed existing stakes and 46 added.

The largest buyer was ClearBridge Investments, adding an estimated $25M. The largest seller was Fidelity Investments, cutting an estimated $8.9M.

  • 135 institutional investors held Immunogen Inc (IMGN) as of Q4 2013, down from 141 in Q3 2013.
  • Funds reported $1.11B of Immunogen Inc stock for Q4 2013, down 12% quarter-over-quarter.
  • 12 funds opened new Immunogen Inc positions in Q4 2013 and 17 closed out, a net change of -5 holders.
  • The largest Immunogen Inc buyer in Q4 2013 was ClearBridge Investments, an estimated $25M added.
  • The largest Immunogen Inc seller in Q4 2013 was Fidelity Investments, an estimated $8.9M sold.

Based on aggregated 13F filings for Q4 2013.